We are thrilled to announce that ALPS Global Holding Berhad has achieved another major milestone on its journey to becoming a publicly traded company. The company’s Form F-4 (Prospectus) has been officially filed and is now publicly available with the U.S. Securities and Exchange Commission (SEC).
This marks a significant step forward as ALPS Global Holding Berhad prepares for its much-anticipated listing on Nasdaq, solidifying its position as a global leader in biotechnology and personalized medicine.
The Form F-4 Prospectus provides detailed insights into our company’s operations, financials, and growth strategy, offering stakeholders a comprehensive view of ALPS’ vision for the future.
We invite you to explore this pivotal document and learn more about the exciting journey ahead:
This achievement reflects the dedication and hard work of our incredible team, as well as the unwavering support of our stakeholders. Together, we are driving innovation, expanding access to life-changing treatments, and creating a healthier, more equitable future for all.
Stay tuned for more updates as we move closer to our Nasdaq debut!
